Genome-scale modeling of human metabolism - a systems biology approach

Biotechnology Journal

Volumn 8, Issue 9, 2013, Pages 985-996

  Mardinoglu, Adil ^a   Gatto, Francesco ^a   Nielsen, Jens ^a  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

Genome scale metabolic models; Human Metabolic Reaction database; Personalized medicine; Systems biology; Whole body modeling

Indexed keywords

GENOME-SCALE METABOLIC MODELS; METABOLIC REACTIONS; PERSONALIZED MEDICINES; SYSTEMS BIOLOGY; WHOLE-BODY;

DISEASE CONTROL; GEMS; GENES; PHYSIOLOGY;

METABOLISM;

BIOINFORMATICS; CANCER GENETICS; CELL TYPE; COMPUTER MODEL; DRUG TARGETING; GENETIC MODEL; GENOME; GENOMICS; GENOTYPE; HIGH THROUGHPUT SEQUENCING; HUMAN; LIPIDOMICS; MARKER GENE; METABOLIC DISORDER; METABOLISM; MOLECULAR MECHANICS; PERSONALIZED MEDICINE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SIMULATION;

GENOME-SCALE METABOLIC MODELS; HUMAN METABOLIC REACTION DATABASE; PERSONALIZED MEDICINE; SYSTEMS BIOLOGY; WHOLE-BODY MODELING;

COMPUTER SIMULATION; DATA MINING; DATABASES, FACTUAL; DRUG DISCOVERY; GENOME, HUMAN; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; INDIVIDUALIZED MEDICINE; METABOLIC NETWORKS AND PATHWAYS; METABOLISM; MODELS, BIOLOGICAL; NEOPLASMS; SYSTEMS BIOLOGY; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84883384697     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201200275     Document Type: Review

References (94)

1. Lazar, M. A., Birnbaum, M. J., De-meaning of metabolism. Science 2012, 336, 1651-1652.
2. DeBerardinis, R. J., Thompson, C. B., Cellular metabolism and Disease: What do metabolic outliers teach us? Cell 2012, 148, 1132-1144.
3. Malik, V. S., Popkin, B. M., Bray, G. A., Despres, J. P., Hu, F. B., Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121, 1356-1364.
4. Hummasti, S., Hotamisligil, G. S., Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ. Res. 2010, 107, 579-591.
5. Nielsen, J., Systems biology of lipid metabolism: from yeast to human. FEBS Lett. 2009, 583, 3905-3913.
6. Thiele, I., Palsson, B. O., A protocol for generating a high-quality genome-scale metabolic reconstruction. Nat. Protoc. 2010, 5, 93-121.
7. Mardinoglu, A., Nielsen, J., Systems medicine and metabolic modelling. J. Intern. Med. 2012, 271, 142-154.
8. Shen, Y., Liu, J., Estiu, G., Isin, B. et al., Blueprint for antimicrobial hit discovery targeting metabolic networks. Proc. Natl. Acad. Sci. USA 2010, 107, 1082-1087.
9. Barabasi, A. L., Gulbahce, N., Loscalzo, J., Network medicine: A network-based approach to human disease. Nat. Rev. Genet. 2011, 12, 56-68.
10. Kitano, H., Systems biology: A brief overview. Science 2002, 295, 1662-1664.
11. Price, N. D., Reed, J. L., Palsson, B. O., Genome-scale models of microbial cells: Evaluating the consequences of constraints. Nat. Rev. Microbiol. 2004, 2, 886-897.
12. Lewis, N. E., Nagarajan, H., Palsson, B. O., Constraining the metabolic genotype-phenotype relationship using a phylogeny of in silico methods. Nat. Rev. Microbiol. 2012, 10, 291-305.
13. Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I. et al., Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc. Natl. Acad. Sci. USA 2007, 104, 1777-1782.
14. Ma, H., Sorokin, A., Mazein, A., Selkov, A. et al., The Edinburgh human metabolic network reconstruction and its functional analysis. Mol. Syst. Biol. 2007, 3, 135.
15. Hao, T., Ma, H. W., Zhao, X. M., Goryanin, I., Compartmentalization of the Edinburgh human metabolic network. BMC Bioinformatics 2010, 11, 393.
16. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., Hirakawa, M., KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 2010, 38, D355-D360.
17. Agren, R., Bordel, S., Mardinoglu, A., Pornputtapong, N. et al., Reconstruction of genome-scale active metabolic metworks for 69 human cell types and 16 cancer types Using INIT. PLOS Comput. Biol. 2012, 8, e1002518.
18. Mardinoglu, A., Agren, R., Kampf, C., Asplund, A. et al., Integration of clinical data with a genome-scale metabolic model of the human adipocyte. Mol. Syst. Biol. 2013, 9, 649.
19. Croft, D., O'Kelly, G., Wu, G. M., Haw, R. et al., Reactome: A database of reactions, pathways and biological processes. Nucleic Acids Res. 2011, 39, D691-D697.
20. Gille, C., Bolling, C., Hoppe, A., Bulik, S. et al., HepatoNet1: A comprehensive metabolic reconstruction of the human hepatocyte for the analysis of liver physiology. Mol. Syst. Biol. 2010, 6, 411.
21. Harkewicz, R., Dennis, E. A., Applications of mass spectrometry to lipids and membranes. Ann. Rev. Biochem. 2010, 80, 301-325.
22. Romero, P., Wagg, J., Green, M. L., Kaiser, D. et al., Computational prediction of human metabolic pathways from the complete human genome. Genome Biol. 2005, 6, R2.
23. Degtyarenko, K., de Matos, P., Ennis, M., Hastings, J. et al., ChEBI: A database and ontology for chemical entities of biological interest. Nucleic Acids Res. 2008, 36, D344-350.
24. Apweiler, R., Martin, M. J., O'Donovan, C. Magrane, M. et al., Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 2011, 39, D214-D219.
25. Cotter, D., Maer, A., Guda, C., Saunders, B., Subramaniam, S., LMPD: Lipid maps proteome database. Nucleic Acids Res. 2006, 34, D507-D510.
26. Lundberg, E., Uhlen, M., Creation of an antibody-based subcellular protein atlas. Proteomics 2010, 10, 3984-3996.
27. Kumar, V. S., Dasika, M. S., Maranas, C. D., Optimization based automated curation of metabolic reconstructions. BMC Bioinformatics 2007, 8, 212.
28. Shlomi, T., Cabili, M. N., Herrgard, M. J., Palsson, B. O., Ruppin, E., Network-based prediction of human tissue-specific metabolism. Nat. Biotechnol. 2008, 26, 1003-1010.
29. Akesson, M., Forster, J., Nielsen, J., Integration of gene expression data into genome-scale metabolic models. Metab. Eng. 2004, 6, 285-293.
30. Becker, S. A., Palsson, B. O., Context-specific metabolic networks are consistent with experiments. PLOS Comput. Biol. 2008, 4, e1000082.
31. Jerby, L., Shlomi, T., Ruppin, E., Computational reconstruction of tissue-specific metabolic models: Application to human liver metabolism. Mol. Syst. Biol. 2010, 6, 401.
32. Jensen, P. A., Papin, J. A., Functional integration of a metabolic network model and expression data without arbitrary thresholding. Bioinformatics 2011, 27, 541-547.
33. van Berlo, R. J. P., de Ridder, D., Daran, J. M., Daran-Lapujade, P. A. S. et al., Predicting metabolic fluxes using gene expression differences as constraints. IEEE/ACM Trans. Comput. Biol. 2011, 8, 206-216.
34. Bordbar, A., Mo, M. L., Nakayasu, E. S., Schrimpe-Rutledge, A. et al., Model-driven multi-omic data analysis elucidates metabolic immunomodulators of macrophage activation. Mol. Syst. Biol. 2012, 8, 558.
35. Schmidt, B. J., Papin, J. A., Musante, C. J., Mechanistic systems modeling to guide drug discovery and development. Drug Discov. Today 2013, 18, 116-27.
36. Su, A. I., Wiltshire, T., Batalov, S., Lapp, H. et al., A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 2004, 101, 6062-6067.
37. Wishart, D. S., Tzur, D., Knox, C., Eisner, R. et al., HMDB: The human metabolome database. Nucleic Acids Res. 2007, 35, D521-D526.
38. Chang, R. L., Xie, L., Xie, L., Bourne, P. E., Palsson, B. O., Drug off-target effects predicted using structural analysis in the context of a metabolic network model. PLOS Comput. Biol. 2010, e1000938.
39. Lewis, N. E., Schramm, G., Bordbar, A., Schellenberger, J. et al., Large-scale in silico modeling of metabolic interactions between cell types in the human brain. Nat. Biotechnol. 2010, 28, 1279-1285.
40. Bordbar, A., Lewis, N. E., Schellenberger, J., Palsson, B. O., Jamshidi, N., Insight into human alveolar macrophage and M. tuberculosis interactions via metabolic reconstructions. Mol. Syst. Biol. 2010, 6, 422.
41. Karlstaedt, A., Fliegner, D., Kararigas, G., Ruderisch, H. S. et al., CardioNet: A human metabolic network suited for the study of cardiomyocyte metabolism. BMC Syst. Biol. 2012, 6, 114.
42. Bordbar, A., Feist, A. M., Usaite-Black, R., Woodcock, J. et al., A multi-tissue type genome-scale metabolic network for analysis of whole-body systems physiology. BMC Syst. Biol. 2011, 180.
43. Hanahan, D., Weinberg, R. A., Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674.
44. Cairns, R. A., Harris, I. S., Mak, T. W., Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11, 85-95.
45. Cheong, H., Lu, C., Lindsten, T., Thompson, C. B., Therapeutic targets in cancer cell metabolism and autophagy. Nat. Biotechnol. 2012, 30, 671-678.
46. Jerby, L., Ruppin, E., Predicting drug targets and biomarkers of cancer via genome-scale metabolic modeling. Clin. Cancer Res. 2012, 18, 5572-5584.
47. Tomita, M., Kami, K., Cancer. Systems biology, metabolomics, and cancer metabolism. Science 2012, 336, 990-991.
48. Folger, O., Jerby, L., Frezza, C., Gottlieb, E. et al., Predicting selective drug targets in cancer through metabolic networks. Mol. Syst. Biol. 2011, 501.
49. Frezza, C., Zheng, L., Folger, O., Rajagopalan, K. N. et al., Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 2011, 477, 225-U132.
50. Jerby, L., Wolf, L., Denkert, C., Stein, G. Y. et al., Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer. Cancer Res. 2012, 72, 5712-5720.
51. Patil, K. R., Nielsen, J., Uncovering transcriptional regulation of metabolism by using metabolic network topology. Proc. Natl. Acad. Sci. USA 2005, 102, 2685-2689.
52. Palsson, B., Zengler, K., The challenges of integrating multi-omic data sets. Nat. Chem. Biol. 2010, 6, 787-789.
53. Yizhak, K., Benyamini, T., Liebermeister, W., Ruppin, E., Shlomi, T., Integrating quantitative proteomics and metabolomics with a genome-scale metabolic network model. Bioinformatics 2010, 26, i255-i260.
54. Ideker, T., Krogan, N. J., Differential network biology. Mol. Syst. Biol. 2012, 8, 565.
55. Palsson, B., Metabolic systems biology. FEBS Lett. 2009, 583, 3900-3904.
56. Famili, I., Forster, J., Nielson, J., Palsson, B. O., Saccharomyces cerevisiae phenotypes can be predicted by using constraint-based analysis of a genome-scale reconstructed metabolic network. Proc. Natl. Acad. Sci. USA 2003, 100, 13134-13139.
57. Blazier, A. S., Papin, J. A., Integration of expression data in genome-scale metabolic network reconstructions. Front. Physiol. 2012, 3, 299.
58. Orth, J. D., Thiele, I., Palsson, B. O., What is flux balance analysis? Nat. Biotechnol. 2010, 28, 245-248.
59. Schuetz, R., Kuepfer, L., Sauer, U., Systematic evaluation of objective functions for predicting intracellular fluxes in Escherichia coli. Mol. Syst. Biol. 2007, 119.
60. Feist, A. M., Palsson, B. O., The growing scope of applications of genome-scale metabolic reconstructions using Escherichia coli. Nat. Biotechnol. 2008, 26, 659-667.
61. Sauer, U., Metabolic networks in motion: C-13-based flux analysis. Mol. Syst. Biol. 2006, 2, 62.
62. Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N. et al., Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 2012, 336, 1040-1044.
63. Metallo, C. M., Walther, J. L., Stephanopoulos, G., Evaluation of C-13 isotopic tracers for metabolic flux analysis in mammalian cells. J. Biotechnol. 2009, 144, 167-174.
64. Walther, J. L., Metallo, C. M., Zhang, J., Stephanopoulos, G., Optimization of C-13 isotopic tracers for metabolic flux analysis in mammalian cells. Metab. Eng. 2012, 14, 162-171.
65. Bordel, S., Agren, R., Nielsen, J., Sampling the solution space in genome-scale metabolic networks reveals transcriptional regulation in key enzymes. PLOS Comput. Biol. 2010, 6, e1000859.
66. Barrett, C. L., Kim, T. Y., Kim, H. U., Palsson, B. O., Lee, S. Y., Systems biology as a foundation for genome-scale synthetic biology. Curr. Opin. Biotech. 2006, 17, 488-492.
67. Nielsen, J., It is all about metabolic fluxes. J. Bacteriol. 2003, 185, 7031-7035.
68. Ward, P. S., Thompson, C. B., Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate. Cancer Cell 2012, 21, 297-308.
69. Herling, A., Konig, M., Bulik, S., Holzhutter, H. G., Enzymatic features of the glucose metabolism in tumor cells. FEBS J. 2011, 278, 2436-2459.
70. Kell, D. B., Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov. Today 2006, 11, 1085-1092.
71. Baumgartner, C., Osl, M., Netzer, M., Baumgartner, D., Bioinformatic-driven search for metabolic biomarkers in disease. J. Clin. Bioinform. 2011, 1, 2.
72. Schnackenberg, L. K., Beger, R. D., The role of metabolic biomarkers in drug toxicity studies. Toxicol. Mech. Meth. 2008, 18, 301-311.
73. Brooks-Worrell, B., Narla, R., Palmer, J. P., Biomarkers and immune-modulating therapies for Type 2 diabetes. Trends Immunol. 2012, 33, 546-553.
74. Shlomi, T., Cabili, M. N., Ruppin, E., Predicting metabolic biomarkers of human inborn errors of metabolism. Mol. Syst. Biol. 2009, 5.
75. Miyagi, Y., Higashiyama, M., Gochi, A., Akaike, M. et al., Plasma free amino acid profiling of five types of cancer patients and its application for early detection. PLOS One 2011, 6, e24143.
76. Baranano, D. E., Rao, M., Ferris, C. D., Snyder, S. H., Biliverdin reductase: A major physiologic cytoprotectant. Proc. Natl. Acad. Sci. USA 2002, 99, 16093-16098.
77. Sung, J. Y., Wang, Y. L., Chandrasekaran, S., Witten, D. M., Price, N. D., Molecular signatures from omics data: From chaos to consensus. Biotechnol. J. 2012, 7, 946-957.
78. Hood, L., Balling, R., Auffray, C., Revolutionizing medicine in the 21st century through systems approaches. Biotechnol. J. 2012, 7, 992-1001.
79. Deisboeck, T. S., Personalizing medicine: A systems biology perspective. Mol. Syst. Biol. 2009, 5, 249.
80. Campion, J., Milagro, F. I., Martinez, J. A., Individuality and epigenetics in obesity. Obes. Rev. 2009, 10, 383-392.
81. Snyderman, R., Personalized health care: From theory to practice. Biotechnol. J. 2012, 7, 973-979.
82. Tian, Q., Price, N. D., Hood, L., Systems cancer medicine: Towards realization of predictive, preventive, personalized and participatory (P4) medicine. J. Intern. Med. 2012, 271, 111-121.
83. Nielsen, J., Translational and systems medicine introduction. J. Intern. Med. 2012, 271, 108-110.
84. Krauss, M., Schaller, S., Borchers, S., Findeisen, R. et al., Integrating cellular metabolism into a multiscale whole-body model. PLOSComput. Biol. 2012, 8, e1002750.
85. Meibohm, B., Derendorf, H., Basic concepts of pharmacokinetic/pharmacodynamic (PK/PD) modelling. Int. J. Clin. Pharm. Th. 1997, 35, 401-413.
86. Bois, F. Y., Jamei, M., Clewell, H. J., PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. Toxicology 2010, 278, 256-267.
87. Rowland, M., Peck, C., Tucker, G., Physiologically-based [harmacokinetics in drug development and regulatory science. Ann. Rev. Pharmacol. 2011, 51, 45-73.
88. Karlsson, F. H., Nookaew, I., Petranovic, D., Nielsen, J., Prospects for systems biology and modeling of the gut microbiome. Trends Biotechnol. 2011, 29, 251-8.
89. Karlsson, F. H., Ussery, D. W., Nielsen, J., Nookaew, I., A closer look at bacteroides: Phylogenetic relationship and genomic implications of a life in the human gut. Microb. Ecol. 2011, 61, 473-485.
90. Karlsson, F. H., Fak, F., Nookaew, I., Tremaroli, V. et al., Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 2012, 3, 1245.
91. Qin, J. J., Li, Y. R., Cai, Z. M., Li, S. H. et al., A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55-60.
92. Gill, S. R., Pop, M., Deboy, R. T., Eckburg, P. B. et al., Metagenomic analysis of the human distal gut microbiome. Science 2006, 312, 1355-1359.
93. Cregg, P. J., Murphy, K., Mardinoglu, A., Inclusion of interactions in mathematical modelling of implant assisted magnetic drug targeting. Appl. Math. Model. 2012, 36, 1-34.
94. Mardinoglu, A., Cregg, P. J., Murphy, K., Curtin, M., Prina-Mello, A., Theoretical modelling of physiologically stretched vessel in magnetisable stent assisted magnetic drug targeting application. J. Magn. Magn. Mater. 2011, 323, 324-329.